-
Neurochem Inc.
Distance: 8.1 Mi275 Armand Frappier Boulevard
H7V 4A7 Laval -
Scimega Research Inc
Distance: 8.5 Mi1695 boul Laval Ste 420
H7S 2M2 Laval -
Elkimia
Distance: 11.8 Mi6221 Des Rossignols
H7L 5T6 Laval -
Aeterna Zentaris Inc
Distance: 140.4 Mi1405 boul du Parc-Technologique
G1P 4P5 Quebec -
Therapex
Distance: 513.9 MiTherapex Division 11065 L-H-Lafontaine
H1J 2Z4 Anjou
GeneChem Technologies Venture Fund
- 1001 De Maisonneuve Boulevard West Suite 920
- Montreal, Quebec
- H3A 3C8
- Phone: (514) 849-7696
- Website
Website Links
Description
Dr. Clement possesses over twenty years of experience in preclinical and clinical drug development, project and alliance management, and product acquisition. Dr. Clement co-founded iCo Therapeutics in 2005 and served as Chief Technology and Development Officer and Chief Business Officer during his tenure with the company.
In addition, our experienced medicinal chemists can also collaborate on an FTE effort to provide impact on your project, from hit-to-lead identification and lead optimization to clinical candidates. Moreover, our senior biochemist with hands on experience in biology can assist your team by providing expertise in assay development and screening efforts to improve your efficiency.